OnKure Therapeutics, Inc. (OKUR) Stock
OnKure Therapeutics stock price chart
OKUR stock quote & key statistics
OnKure Therapeutics annual financials
Income statement →| Fiscal year | Revenue | Net income | EPS |
|---|---|---|---|
| FY2025 | $0 | -$59.5M | -$4.41 |
| FY2024 | $0 | -$52.7M | -$6.36 |
| FY2023 | $0 | -$35.3M | -$25.22 |
| FY2022 | $0 | -$29.5M | -$21.21 |
Fiscal year ending December 31. Source: company filings via EODHD.
About OnKure Therapeutics, Inc.
OnKure Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of precision medicines that target biologically validated drivers of cancers and other diseases. Its lead product candidate includes OKI-219, a selective inhibitor of phosphoinositide 3-kinase alpha (PI3Ka) harboring the H1047R mutation that is in Phase 1 clinical trial for the treatment of solid tumors, including breast cancer. The company was founded in 2011 and is headquartered in Boulder, Colorado.
OnKure Therapeutics stock FAQ
What is the OnKure Therapeutics stock ticker symbol?
OnKure Therapeutics, Inc. trades on the NASDAQ under the ticker symbol OKUR.
What sector and industry is OnKure Therapeutics in?
OnKure Therapeutics, Inc. is classified in the Healthcare sector, Biotechnology industry.
How many employees does OnKure Therapeutics have?
OnKure Therapeutics, Inc. has about 45 full-time employees.
What were OnKure Therapeutics's revenue and earnings last fiscal year?
OnKure Therapeutics reported revenue of $0 and net income of -$59.5M in fiscal 2025, with earnings per share of -$4.41.
Is OnKure Therapeutics in the Russell 2000?
Yes. OnKure Therapeutics, Inc. (OKUR) is a component of the Russell 2000, the benchmark index of U.S. small-cap stocks.
When did OnKure Therapeutics go public?
OnKure Therapeutics stock began trading on October 7, 2024.
Russell 2000 Biotechnology stocks
All Russell 2000 →- CGONCG Oncology
- COGTCogent Biosciences
- CRSPCRISPR Therapeutics
- CYTKCytokinetics
- DFTXDefinium Therapeutics
- DNTHDianthus Therapeutics
- IBRXImmunityBio
- IOVAIovance Biotherapeutics
- KODKodiak Sciences
- KRYSKrystal Biotech
- KYMRKymera Therapeutics
- LGNDLigand Pharmaceuticals
- MIRMMirum Pharmaceuticals
- ORKAOruka Therapeutics
- PCVXVaxcyte
- PRAXPraxis Precision Medicines
- PTCTPTC Therapeutics
- PTGXProtagonist Therapeutics
- RYTMRhythm Pharmaceuticals
- SRRKScholar Rock
- SYRESpyre Therapeutics
- TGTXTG Therapeutics
- TVTXTravere Therapeutics
- TWSTTwist Bioscience